Mayo Clinic expert explains new vaccine options for next influenza season

The next flu shot season will include several new vaccine options for consumers, Mayo Clinic vaccine expert Gregory Poland, M.D., says. Fearful of needles? There's now an influenza vaccination just for you. Allergic to eggs? It won't stop you from getting a flu shot. The new choices move influenza vaccinations closer to the personalized approach long sought by immunologists including Dr. Poland, but they may also prove bewildering to patients, he says.

"I think what's really going to be confusing to patients and to doctors and nurses is that we'll have seven different choices this year. We're used to the , we're used to the nasal spray, and that's all we've had, forever," says Dr. Poland, who heads the Mayo Clinic Vaccine Research Group and the Mayo Clinic Program in Translational Immunovirology and Biodefense.

The new options available for the upcoming include:

*A shot with four strains of influenza rather than the traditional three strains.

*Nasal sprays with four strains rather than the usual three strains.

*A high-dose vaccine for the elderly, to boost their immune response and protection.

*For those with , two new vaccines without egg proteins.

*For the needle-phobic, a new vaccine delivered by a tiny needle called a micro-needle into the skin, rather than by a regular needle under the skin.

"So lots of choices of different kinds of vaccines that tend to be targeted toward individual age groups and fears, for example a needle fear. It really is ushering in a new era of individualized, or personalized, medicine," Dr. Poland says. "Instead of 'one size fits all,' this is a very real example of the incredible advances happening in medicine, where there's not one choice for everybody, there's a best choice for each individual, and that's what's happening with flu vaccines."

Work by Dr. Poland and the Mayo Clinic Vaccine Research Group includes research into what they call "vaccinomics"  — the development of personalized vaccines based on the growing understanding of the role genetics play in how and why people respond to vaccines differently, including influenza vaccines.

add to favorites email to friend print save as pdf

Related Stories

FDA approves first 4-in-1 flu vaccine

Feb 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

EU tackles Ebola response

1 hour ago

European Union foreign ministers thrashed out measures to help halt Ebola's deadly spread on Monday, as Nigeria—Africa's most populous country—was expected to be declared free of the disease.

WHO declares Nigeria Ebola-free (Update)

2 hours ago

Africa's most populous nation Nigeria was on Monday declared officially Ebola free but warned that it remained vulnerable as long as the virus was raging elsewhere in west Africa.

User comments